FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to therapy and infectious diseases, and can be used for preventing and treating bronchial asthma, complicating respiratory viral infections and other respiratory inflammatory diseases. That is ensured by a combined inhibition of p-gene of the respiratory syncytial virus (further - RSV) and anti-inflammatory murine il-5 gene; p-gene of the RSV required for the cell replication is inhibited using a created molecule of small interfering RNA (siRNA) - SEQ ID NO 1 (siP1), while anti-inflammatory murine il-5 gene is inhibited using a created molecule of siRNA - SEQ ID NO 15 (siIL4-408). They are used to develop preparations containing therapeutically effective amounts thereof to be used intranasally.
EFFECT: method enables relieving signs of the allergic inflammation and a severity of RSV-infection by inhibiting anti-inflammatory murine il-5 gene and inhibiting the RSV virus replication.
2 cl, 17 dwg, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ALLERGIC BRONCHIAL ASTHMA TREATMENT, BASED ON CYTOKINES IL-4 AND IL-13 GENES EXPRESSION INHIBITION USING SIRNA MOLECULES | 2016 |
|
RU2615463C1 |
APPLICATION OF COMPOSITION CONSISTING OF CATIONIC LTP PEPTIDE AND MOLECULES OF RNA AGAINST RESPIRATORY VIRUSES | 2015 |
|
RU2609857C1 |
COMPOSITION FOR INTERLEUKINE-4 CYTOKINE GENE SILENCING | 2014 |
|
RU2563989C1 |
COMPOSITION INHIBITING EXPRESSION OF INTERLEUKIN-4 AND INTERLEUKIN-13 GENES FOR THERAPY OF ALLERGIC RHINITIS | 2018 |
|
RU2710895C1 |
F-PROTEIN OF RESPIRATORY SYNCYTIAL VIRUS AND ITS USE | 2007 |
|
RU2464316C2 |
AGENT FOR INHIBITION OF REPLICATION OF SARS-COV-2 VIRUS MEDIATED BY RNA INTERFERENCE | 2020 |
|
RU2733361C1 |
VACCINE AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV) | 2014 |
|
RU2723328C2 |
RNAI-MODULATION OF RSV, PIV AND OTHER RESPIRATORY VIRUSES AND APPLICATION THEREOF | 2005 |
|
RU2409666C2 |
COMBINED DRUG WITH ANTIVIRAL EFFECT AGAINST NEW SARS-COV-2 CORONAVIRUS | 2021 |
|
RU2746362C1 |
IRNA AGENT FOR REDUCING LEVELS OF VIRAL PROTEIN, IRNA OR RESPIRATORY SYNCYTIAL VIRUS TITRE IN RESPIRATORY CELL | 2005 |
|
RU2494745C2 |
Authors
Dates
2014-08-20—Published
2012-09-27—Filed